Search Results - "Beutner, K R"
-
1
Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults
Published in Antimicrobial Agents and Chemotherapy (01-07-1995)“…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
Get full text
Journal Article -
2
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
Published in Journal of the American Academy of Dermatology (01-12-1999)“…Background: Basal cell carcinoma (BCC) responds to interferon therapy. Imiquimod is a cytokine and interferon inducer. Objective: This randomized, double-blind…”
Get full text
Journal Article -
3
Treatment of genital warts with an immune-response modifier (imiquimod)
Published in Journal of the American Academy of Dermatology (01-02-1998)“…Background: Genital warts are a common sexually transmitted disease caused by human papillomavirus. Imiquimod is a novel immune-response modifier capable of…”
Get full text
Journal Article -
4
Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy
Published in Antiviral Research (01-12-1995)“…Oral administration of the prodrug valacyclovir results in enhanced bioavailability and significantly greater plasma concentrations of acyclovir than can be…”
Get full text
Book Review Journal Article -
5
Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts
Published in Antimicrobial Agents and Chemotherapy (01-04-1998)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
6
Polyphenon E®: a new treatment for external anogenital warts
Published in British journal of dermatology (1951) (01-01-2010)“…Summary Background External genital warts (EGWs, condylomata acuminata) are a common, highly contagious disease caused by human papillomavirus (HPV),…”
Get full text
Journal Article -
7
Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest
Published in The pharmacogenomics journal (22-05-2018)“…Four single nucleotide polymorphism (SNP)-based human leukocyte antigen (HLA) imputation methods (e-HLA, HIBAG, HLA*IMP:02 and MAGPrediction) were trained…”
Get full text
Journal Article -
8
External Genital Warts: Report of the American Medical Association Consensus Conference
Published in Clinical infectious diseases (01-10-1998)“…A consensus process was undertaken to describe and evaluate current information and practice regarding the diagnosis, treatment, and evaluation of patients…”
Get full text
Journal Article Conference Proceeding -
9
Genital Warts and Their Treatment
Published in Clinical infectious diseases (01-01-1999)“…Genital warts are manifestations of a common viral sexually transmitted disease (STD) that are often diagnosed and treated with a variety of clinical…”
Get full text
Journal Article Conference Proceeding -
10
Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes
Published in The New England journal of medicine (01-01-2004)“…This controlled trial was conducted in 1484 heterosexual couples in whom one partner had symptomatic genital herpes simplex virus type 2 (HSV-2) infection…”
Get full text
Journal Article -
11
Nongenital human papillomavirus infections
Published in Clinics in laboratory medicine (01-06-2000)“…Although genital HPV types produce a broad spectrum of disease, the nongenital types are a bit more predictive. Particularly in the immunocompromised patient,…”
Get more information
Journal Article -
12
Human papillomavirus infection
Published in Journal of the American Academy of Dermatology (01-01-1989)Get more information
Journal Article -
13
Clinical management of herpes zoster in the elderly patient
Published in Comprehensive therapy (01-03-1996)Get more information
Journal Article -
14
Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis
Published in International journal of dermatology (01-06-1998)“…A multi‐center, randomized, double‐blind, placebo‐controlled trial was performed to evaluate the effectiveness of butenafine, a fungicidal benzylamine…”
Get full text
Journal Article -
15
Epidemiology of human papillomavirus infections
Published in Dermatologic clinics (01-04-1991)“…Human papillomavirus infection represents the most common mucocutaneous viral infection, and 3% to 5% of all patients have clinically evident warts. Human…”
Get more information
Journal Article -
16
Patient-applied podofilox for treatment of genital warts
Published in The Lancet (British edition) (15-04-1989)“…In a double-blind trial, 0.5% podofilox (podophyllotoxin) or placebo was applied by patients to their own genital warts in up to four treatment cycles. At some…”
Get more information
Journal Article -
17
Patient-applied treatment for external genital warts: the time has come
Published in The Western journal of medicine (01-10-1998)Get full text
Journal Article -
18
Cutaneous viral infections
Published in Pediatric annals (01-04-1993)Get more information
Journal Article -
19
Topical podofilox for the treatment of condylomata acuminata in women
Published in Obstetrics and gynecology (New York. 1953) (01-10-1990)“…The purpose of this study was to determine the efficacy and safety of 0.5% podofilox solution (Condylox) for the treatment of genital warts in women…”
Get more information
Journal Article -
20
Podophyllotoxin in the treatment of genital warts
Published in Current problems in dermatology (1996)Get more information
Journal Article